emblem

DIRECTORATE GENERAL OF HEALTH SERVICES

Ministry of Health & Family Welfare
Government of India

Public Health

INSTITUTE OF SEROLOGY KOLKATA

1. Introduction: Institute of Serology Kolkata was established on 17th September, 1912 and is now a subordinate office of Directorate General of Health Services, under the Ministry of Health & F.W. of India. Current activities of the Institute are as under;

i. Production of various quality diagnostic reagents like Antigen, species specific Antisera, Anti H Lectin etc. and supply to the Government and Non-Government Institutions like Forensic Science Laboratories and Hospitals all over the country.

ii. Forensic Serology for determination of origin of species of different biological exhibits and undertake blood group serology in case the species origin is human.

iii. Institute also serve as National Referral Laboratory for identification of Measles and Rubella

iv. Training of Laboratory Technicians in various fields of Serology and Sexually Transmitted Diseases and imparting training in Forensic Serology to post graduate students of Forensic Medicine.

v. Referral laboratory/Centre for A, B, O Blood grouping & Rh typing, V. D. Serology, Isolation of Polio Virus.

2. Administrative Activities

2.1. Staff Strength:

• Total Sanctioned Strength of staff -93

• Staff in position at IOSK -60

• Vacant positions at IOSK -36

• % vacant position at IOSK -35.48% Consolidated status of the staff is given in the table No.1.

Table No. 1

Group-wise staff position of CRI Kasauli

S. No. Staff sanctioned strength Staff in-position Vacant positions % Vacancies

1

Group-A

9

6

3

33.33

2

Group-B (Gaz)

2

0

2

100.00

3

Group-B(NG)

5

1

4

80.00

4

Group-C (Technical)

53

32

21

39.62

 

Group C (Ministerial)

24

21

3

12.50

 

Total

93

60

33

35.48

Detailed staff position is given in Annexure 1

2.2Budget Performance:

  • BE 2015-16 is Rs. 630.00 lakh (Plan Rev Rs. 55.00 lakh and Non-plan Rs. 575.00 lakh)
  • RE 2015-16 Rs. xx lakh (Plan Rev Rs. 7.04 lakh and Non-plan Rs. 284.49 lakh)
  • FE 2015-16 Rs. xx lakh (Plan Rev Rs. 45.50 lakh and Non-plan Rs. 594.39 lakh).
  • Expenditure 2015-16 xx
  • % Utilization against FE is xx (Plan Rev 7.82% and Non-plan 50.45%).
  • BE 2015-16 is Rs. 634.00 lakh (Plan Rs. 34.00 lakh and non-plan Rs. 600.00 lakh)

Consolidated allocation & utilization of budget 2013-14 is given in table No. 2.

Table No. 2

Budget Provisions

(Rs. in Lakh)

S. No Year Plan Non-Plan Total

1

BE 2015-16

55.00

575.00

630.00

2

RE 2015-16

55.00

575.00

630.00

3

FE 2015-16

   

0

4

Expenditure 2015-16

   

0

5

% Expenditure against FE

   

0

6

BE 2016-17

34.00

600.00

634.00

3. Technical support Services:

3.1. Medico-legal Section:

S. No Samples No. of fresh samples received No. of samples analyzed

No. of samples reported

I

Forensic Cases)

1036

   

ii

Forensic Exhibits

4511

   

iii

Items for Species determination

4984

   

iv

Items for Blood Grouping

1111

   
 

Total

 

 

 

3.2. VD Serology

S. No Samples No. samples Received No. Of samples found Positive No. of samples for which Report Given

i

Antenatal cases

-

-

-

ii

STD clinic samples

2537

90

2537

iii

Ref. Lab. Pool

-

-

-

 

Total

2537

90

2537

3.3. STD/Bacteriology Section

S. No Samples No. samples Received No. Samples Positive test 1 No. Of samples positive test 2

i

Syphilis

2637

90 VDRL

137 TPHA

ii

Candida

1992

206 Gram stain

252 Culture

iii

Gonorrhea

1839

06 Direct Smear

00 Culture

iv

B. Veginosis

1992

238 KOH

 

v

Hepatitis B

2329

20 Elisa

29 Immu Rech

vi

Hepatitis C

92

0

2 imm rech

vii

PAP Smear

1755

0

0

viii

HSV – 2

366

48 (ELISA

 

ix

Trichomonas Vaginalis

1992

415 Wet Mount

496 Culture

x

C. Trachomatis

184

59 ELISA

 

xi

Non Herpetic Syndrome

124

3 GiMSA

 

xii

Herpetic Syndrome

68

13 GIMSA

 

xiii

CMV

00

00 ELISA

 

 

Total

 

 

 

 

Production Division

3.4. Antigen and Antibody Production Division (Production, Demand and supplies)

Quantity in Number of Ampoules/vials

S. No Vaccine / Anti-sera Installed Capacity Quantity manufactured Demand received Quantity supplied

i

VDRL Antigen

 

3640 amp

3340 amp

3340 amp

ii

Antisera against animal species

 

4890 ml

2279 ml

4270 ml

 

Total

 

 

 

 

3.5. BGRC Section

Quantity in numbers of Ampoules/Vials

S. No Vaccine / Anti-sera Installed Capacity Quantity manufactured Demand received Quantity supplied  

i

Anti-H Lectin

 

2600 ml

   

ii

A-1 Lectin

 

-

-

-

iii

Blood Grouping antigen

 

537

   

iv

Anti D (Rh factor)

 

19

 

 

 

Total

 

 

 

 

4. Quality Control Division

S. No Lots No. of Lots Received No. of Lots Tested No. of Lots Cleared No. of Lots Rejected

i

Anti-H Lectin

72

72

72

0

ii

Species Anti-serum

18

18

18

0

iii

VDRL Antigen

05

05

05

0

 

Total

95

95

95

0

5. Surveillance section

5.1. National Polio Laboratory

S. No Samples Numbers

i

Total cases/samples received

13024

ii

NPEV positive

1076

iii

L20 B Positive

127

iv

Environment Sample received

208

v

L20 B Positive

226

5.2. Measles Laboratory

5.2.1. Measles samples

S. No Samples Numbers

i

Total cases/samples received

972

ii

No. of samples tested

972

iii

No. of samples found Positive

481

iv

No. of samples found Negative

485

v

No. of samples found equivocal

00

5.2.2. Rubella samples

S. No Samples Numbers

i

Total cases/samples received

432

ii

No. of samples tested

432

iii

No. of samples found Positive

155

iv

No. of samples found Negative

277

v

No. of samples found equivocal

00

BCG VL GUINDY – BRIEF ON ACTIVITIES

1.Introduction:

1.1. Organization

BCGVL Guindy was established in 1948 and currently is a sub-ordinate office of the Directorate General of Health Services (DGHS) under the Ministry of Health and Family Welfare of the Government of India, situated at Guindy, Chennai (Tamilnadu) near King Institute of Preventive Medicine. The institute has a huge complex, which is divided in five major sub-sections i.e. Establishment, Production Division, Quality Control Division, Animal House and Warehousing & Marketing. The other major facilities are Containerization, sterilization, Physical inspection.

1.2. Functions:

The major functions of the institute are production of BCG Vaccine (10 doses) for control of childhood Tuberculosis and supply to Expanded Programme of Immunization (EPI). Institute also manufactures therapeutic BCG Vaccine for management of bladder cancer.

2. Staff Strength

  • sanctioned strength -113
  • Staff in-position -95
  • Requirement as cGMP -151
  • Existing staff suitable -94
  • New psts to be created -57

3. Budget Provisions:

  • Budget Estimates 2015-16 -Rs. 2315.00 lakh
  • RE (2015-16) proposed -Rs. 1684.00 lakh
  • FE 2015-16 -Rs. 1465.00 lakh • Actual expenditure 2015-16 -Rs. 1384.85 lakh
  • BE (2016-17) proposed - Rs. 2255.00lakh

4. Physical Performance of BCG

  • Installed capacity for production of BCG vaccine of 800 lakh doses per annum.
  • The Institute was meeting 100% of demand of BCG vaccines in the country, since 2002-03.
  • However, after the suspension of the manufacturing license in Jan., 2008, the production and supply of the BCG Vaccine from the institute was stopped.

5. Up-gradation of BCG vaccine manufacturing facility:

  • MOH&FW has taken a decision in a meeting under the Chairmanship of Secretary (H) on 1.3.2011, wherein it was decided that the BCGVL will be revived and a new cGMP compliant BCG vaccine manufacturing facility will be created at the exiting site.
  • SFC was approved for creation of new facility for manufacturing of BCG vaccine and for renovation of Allied facilities at BCGVL.
  • Ms. HLL was engaged for up-gradation of BCG vaccine manufacturing facility at BCGVL Chennai and to make it cGMP compliant with a cost of Rs. 64.72 Crores.

Status of completion of new facility as on date;

• Construction & Civil Works -Completed

• Purchase of equipments -Completed

• Installation Qualification -Completed

• Operation Qualification -Completed

• Validation -Completed

• DCG(I) Inspection -Completed

• Trial Batches -Planned from May 2016

• Consistency Batches -Planned from Oct 2016

6. Release of Funds to M/s HLL:

The status of Funds approved under the project and released to M/s HLL as on date are as under;

Total Funds approved as per SFC Rs. 64.72 Crore

Funds released till March 2015 Rs. 57.78 Crore

Balancefunds to released Rs. 6.94 Cro

BRIEF ON CENTRAL RESEARCH INSTITUTE KASAULI

1. Introduction:

1.1. Origin & Concept:

Central Research Institute was established on 3rd May, 1905 as Pasteur Institute for North India. It is a subordinate office of Directorate general of Health Services, under the Ministry of Health & F.W. of India. Since its inception the institute has developed into a premier institute in research and production of a number immunobiologicals.

1.2. Estate & Physical Infrastructure:

Land Area: Estate of CRI Kasauli consists of 67 Acres of land in four pieces situated within a radius of 1.5. Kms. The reference areas are: (i) Manufacturing wing, (ii) R&D wing, (iii) Drum-bar Estate and (iv) Belvedere Estate. CRI Kasauli has residential accommodation that houses about350 employees. The institute has a huge complex which divided in seven sub-sections i.e. Establishment, Academic, Auxiliary Facilities, Production Division, Quality Control Division, Animal House and Research & Surveillance Division.

1.3. Mandate

Central Research Institute is engaged in

  • Large scale production of Bacterial and Viral Vaccines & Sera.
  • Research and Development in the field of immunology and vaccinology.
  • Teaching and training.
  • Quality Control of vaccine and sera

2. Staff Strength:

  • Total sanctioned staff strength -725
  • Staff in-position -460
  • Vacant positions -183
  • Lapsed posts -82

3.Budget Performance:

Budget performance (2015-16):

  • BE allocated is Rs. 5400.00 lakh
  • RE propose (2015-16) is Rs. 5376.13 Lakh
  • FE (2015-16) is Rs. 4220.27 Lakh
  • Budget utilization as on 31.3.2016 is Rs. 3890.83 lakh
  • BE(2016-17) Proposed is Rs. 7102.81 lakh

4.Technical Performance (2015-16):

Production and supplies of vaccine

  • Manufacturing in existing facilities has been started
  • Production in respect of DPT and TT is 41.16 lakh (16.14%) and 69.33% respectively.
  • Supply against demand in respect of DPT and TT is 69.33% and 33.66% respectively.

Details of Batches started, quantity manufactured, and demand received and quantity released is given in table 3.

Table No. 3

Production, demand and supply of the vaccine and anti-sera:

(Quantity in lakh of doses)

S. No

Vaccines & antisera

Installed Capacity

Production

% Produced

Demand

Supplies

% Supplied

1

DPT

255

41.16

16.14%

75.00

52.00

69.33%

2

DT

200

0

       

3

TT

300

35.19

11.735

101.71

34.71

33.66

4.1

YFV (CRIK)

0.35

 

0.00

     

4.2

YFV (IMPORT)

 

0.93

 

0.52

0.41

78.73%

5

ARS

2.5

0.22

8.96%

0.53

0.18

34.66

6

ASVS

3.00

0.015

5.06%

0.069

0.014

20.59%

7

DATS

0.80

0.051

6.4%

0.081

0.042

51.92%

8

NHS

0.004

0

0.00

0.0025

0.0001

4.44%

9

DR

2.75

0.14

5.06%

0.27

0.12

45.07%

Qty. in lakh of vials

5 . Surveillance activities

Samples received for;

  • Salmonella & E.coli -NIL
  • Rabies Research -NIL
  • Influenza Surveillance -105
  • Polio surveillance -4094

6. Research & Development

  • Number of projects in the beginning -Nil
  • Number new projects started -05
  • Number of projects Completed -Nil
  • Number of projects continuing at end -05

7. Medical care facilities provided;

  • OPD care -7194
  • Indoor Admissions -123
  • Lab Investigations -6366
  • Physiotherapy -617
  • Referral -37
  • YF Vaccination -2222
  • Medical Check up -282
  • Dog-bite cases -1034
  • ECG -319
  • Nebulization -231
  • Others -5209

1. Animal House

  • Equines -68
  • Sheep -14
  • Guiea Pigs -580
  • Mice -5250

2. Academic Activities

  • PG Courses -11
  • Project Work -03
  • Practical Training -34

NATIONAL PROGRAMME FOR HEALTH CARE OF ELDERLY

1. Introduction:

National Programme for Health care for Elderly was launched in 2010. EFC for an amount of Rs. 288.00 Crores including 20% of State share was approved in June 2010 for the remaining period of 11th plan. The programme is State oriented and basic thrust of the programme is to provide dedicated health care facilities to the senior citizens (>60 year of age) at various level of primary health care.

1.1. Objectives:

· To provide accessible, affordable, and high-quality long-term, comprehensive and dedicated care services to an Ageing population;

· Creating a new "architecture" for Ageing; to build a framework to create an enabling environment for "a Society for all Ages";

· To promote the concept of Active and Healthy Ageing;

1.2. Expected Outcome of Programme

· Setting up of 325 District Geriatric Units with dedicated Geriatric OPD and 10-bedded Geriatric ward in 80-100 District Hospitals by the end of 12th plan period;

· Setting up of biweekly Geriatric Clinics and Rehabilitation units in all Community Health Centres of selected districts;

· Setting up of weekly Geriatric Clinics in all Primary Health Centres of selected districts;

· Strengthening all sub-centres of selected districts to provide with equipment for community outreach services;

2. Programme Organization:

2.1. Institutional Framework:

· Integration with NRHM

· Constitution of State Health Society (SHS)

· Constitution of District Health Society (DHS)

2.2. Package of Services

· Sub Centre: Health Education and home based care to bedridden elderly persons and provide training to the family health care providers in looking after the disabled elderly persons.

· Primary Health Centre: Conducting weekly geriatric clinic health assessment of the elderly persons and simple investigation including blood sugar, etc.

· Community Health Centre: Conducting biweekly geriatric clinic, organizing rehabilitation services, domiciliary visits by the rehabilitation worker for bed-ridden elderly and counselling to family members for care such patients.

· District Hospitals: Dedicated Geriatric OPD services, In-door admissions through 10 bedded geriatric ward, laboratory investigations and rehabilitation services

2.3. Package of Human Resources:

S. No

Categories of Staff

RGCs

DHs

CHCs

1

prof. of Geriatrics

1

   

2

Assistant Prof Geriatrics

2

   

3

Medical Officers

4

2

 

4

Nurses

16

6

 

5

Physiotherapists

4

1

1

6

Med. Social Worker

1

   

7

Lab. Tech

1

   

8

Programme Assistant

1

   

9

Hospital Attendant

4

2

 

10

Sanitary Attendant

4

2

 
 

Total

38

13

1

2.4. Package of Financial Support

(Amount in lakh of INR)

Budget lines

RMI

DH

CHC

PHC

SHC

Non-Recurring

         

Construction/ renovation

200

80

 

 

 

Mach./Equip./Appliance

50

7

0.5

0.3

0.2

video conferencing

120

0

 

 

 

Total Non-recurring

370

87

0.5

0.3

0.2

Recurring cost

 

 

 

 

 

Mach./Equip./Appliance

10

3

0.5

0.2

0.1

Training & IEC

5

0.8

1.2

0.3

 

Manpower

88.44

28.2

1.8

 

 

Drugs & consumables

20

10

 

 

 

IEC activities

 

2

 

 

 

Research Activities

40

 

 

 

 

Total Recurring

163.44

44

3.5

0.5

0.1

Grand Total

533.44

131.00

4.00

0.80

0.30

3. Expansion of programme during 12th plan period

Years

Districts

RGCs

NCA

Existing

100

8

0

2012-13

     

2013-14

25

4

 

2014-15

25

4

2

2015-16

75

4

 

2016-17

100

0

0

Total

325

20

2

  • 100 Districts are covered under programme as on date
  • 25 new districts are planned to be covered during 2014-15
  • 75 new districts are planned to be covered during 2015-16
  • 125 new districts are planned to be covered during 2014-15

4. Progress in implementation of Programme:

4.1. Progress in implementation of Programme

National programme for Health Care of Elderly was launched in last year of the 11th plan period in 100 districts of 21 states. 4 new districts were inducted under programme during 2013-14. As on date , the programme activities are being implemented in 104 districts. Institutes covered under programme are as under;

Activities Completed

District Hospitals

RGCs

NCAs

Institutions sanctioned till March 2015

96

08

 

Institutions sanctioned during 2015-16

131

05

02

OPD Services Established

71

08

 

Indoor Wards Services

61

04

 

Physiotherapy Services

62

07

 

Equips & Appliances

50

07

 

Drugs & Consumables

45

07

 

Contractual staff Recruited

43

04

 

Training for staff organized

43

04

 

5. Services provided

5.1. Services through District Hospitals and sub-District PHC system:

Institutions

OPD services

Indoor admissions

Physiotherapy

Home visits

Supportive devices given

Distt. Hosptls.

279275

29249

69339

NA

567

CHCs

378367

NA

29601

1532

240

PHCs

197611

NA

NA

2310

48

SCs

NA

NA

NA

8300

280

· Districts Hospitals provided OPD, indoor admission and physiotherapy to 279275, 29249 and 69339 elderly respectively.

· CHCs provided OPD, and physiotherapy services to 378367 and 29601 elderly respectively.

· PHCs provided OPD abd home care services to 197611 and 2310 elderly respectively.

· Home based care to 8300 elderly people and supportive devices to 280 elderly people.

5.2. Services through RGCs

Institutes Identified

OPD Services

Indoor Wards

Physiotherapy

Lab. Tests

IMS, BHU

530

136

471

 

GMC Trivandrum

0

     

GMC Guwahati

1789

126

261

3840

SN MC Jodhpur

0

     

MMC Chennai

       

GMC, Mumbai

6836

 

3824

10093

SEK IMS Srinagar

1660

68

499

1283

AIIMS Delhi

19590

610

1934

38761

Total

30405

942

6990

53979

Last Updated On 15/03/2017